熱門資訊> 正文
Optinose GAAP每股收益-0.12美元，收入1，488万美元
2024-05-14 19:25
- Optinose press release (NASDAQ:OPTN): Q1 GAAP EPS of -$0.12.
- The Company reported $14.9 million in net revenue from sales of XHANCE during the three-month period ended March 31, 2024, an increase of 26% compared to $11.8 million during the three-month period ended March 31, 2023.
More on OptiNose
- OptiNose, Inc. 2023 Q4 - Results - Earnings Call Presentation
- OptiNose, Inc. (OPTN) Q4 2023 Earnings Call Transcript
- OptiNose granted FDA nod to expand labeling for sinusitis therapy
- Seeking Alpha’s Quant Rating on OptiNose
- Historical earnings data for OptiNose
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
